Shanliang Zhong

Central South University of Forestry and Technology — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

46h-index5.9kcitations144works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(63), Circular RNAs in diseases(57), Cancer-related molecular mechanisms research(39), Extracellular vesicles in disease(19), RNA modifications and cancer(15)

Publications144 total

Dissecting sequence determinants of DNA methylation and in silico perturbation
2025
Anatomy of Commodity Futures Returns in ChinaTaking Oil as an Example
Advances in Economics Management and Political Sciences·2025Open Access
P2.15.19 Assessment of NSCLC Treatments and Correlation With Hypogonadism in Male Patients With NSCLC
Journal of Thoracic Oncology·2025
Pre-pregnancy body mass index and offspring neurobehavioral development: a birth cohort study
Frontiers in Nutrition·2025Open Access
Molecular mechanisms of the Suting Pill in the treatment of asthma: A study based on network pharmacology and molecular docking
Medicine·2025Open Access
Applications of single-cell transcriptomics: updated insights in endometrial cancer
Clinical & Translational Oncology·2025
A prognostic risk model construction for endometrial cancer based on inflammation-related genes.
PubMed·2025
Decoding Translation-Related Functional Sequences in 5'UTRs Using Interpretable Deep Learning Models
ArXiv.org·2025Open Access
Single-cell RNA sequencing reveals altered immune and stromal landscape in primary and liver metastasis of gastric cancer
Biochemistry and Biophysics Reports·2025Open Access
CAPTAIN: A multimodal foundation model pretrained on co-assayed single-cell RNA and protein
2025Open Access
Engineered <scp>EVs</scp>‐Mediated <scp>miR</scp>‐222 Targeting <scp>PTEN</scp>/<scp>FN1</scp> Axis Reverses Anthracycline Resistance in <scp>HER2</scp>‐Negative Breast Cancer
Cancer Science·2025· 2 citedOpen Access
tRF-22-WE8SPOX52 promotes progression of breast cancer by down-regulating MAP2K4
Medical Oncology·2025
Identification of a novel tRNA-derived small RNA fragment, tRF-16-2YU04DE, with the potential of inhibiting endometrial cancer progression
Medical Oncology·2025
Polycyclic aromatic hydrocarbons, biological aging, and antioxidant diet associations with cardiometabolic multimorbidity: Mechanistic pathways and precision prevention strategies
Environmental Chemistry and Ecotoxicology·2025· 2 citedOpen Access
Androgen receptor expression and clinical characteristics in breast cancer
World Journal of Surgical Oncology·2024· 3 citedOpen Access
CircABHD2 Inhibits Malignant Progression of Endometrial Cancer by Regulating NAD+/NAMPT Metabolism Axis
Molecular Biotechnology·2024· 1 cited
Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer
Translational Cancer Research·2024· 3 citedOpen Access
Circular RNA HSDL2 promotes breast cancer progression via miR-7978 ZNF704 axis and regulating hippo signaling pathway
Breast Cancer Research·2024· 13 citedOpen Access
circNFIB decreases synthesis of arachidonic acid and inhibits breast tumor growth and metastasis
European Journal of Pharmacology·2023· 10 cited
Single-cell RNA-seq reveals MIF−(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma
Oral Oncology·2023· 14 cited
page 1 of 8Next →

Frequent Co-authors

Jinhai Tang(36), Jianhua Zhao(34), Su‐Jin Yang(21), Siying Zhou(14), Hanzi Xu(12), Xiu Chen(12), Dandan Wang(11), Wei‐xian Chen(10), Heda Zhang(10), Mengmeng Lv(9), Dandan Yu(9), Hongyu Shen(9), Junchen Hou(8), Qian Zhang(7), Yunjie He(7), Dandan Wang(7), Tengfei Ma(6), Jinyan Wang(5), Lin Chen(4), Qing Hu(4)